Evercore Wealth Management, LLC Novo Cure LTD Transaction History

Evercore Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$28.72 - $52.63 $120,624 - $221,046	-4,200 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.0 - $52.4 $134,400 - $220,080	4,200 New	4,200 $220,000
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $52,110 - $63,854	-2,700 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$16.3 - $21.9 $44,010 - $59,129	2,700	2,700 $54,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.13B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Evercore Wealth Management, LLC with notifications on news.